Cargando…

Paratubular basement membrane insudative lesions predict renal prognosis in patients with type 2 diabetes and biopsy-proven diabetic nephropathy

AIMS: Glomerular insudative lesions are a pathological hallmark of diabetic nephropathy (DN). However, paratubular basement membrane insudative lesions (PTBMIL) have not attracted much attention, and the association between such lesions and the renal prognosis remains unclear. METHODS: Among 142 pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Mise, Koki, Yamaguchi, Yutaka, Hoshino, Junichi, Ueno, Toshiharu, Sekine, Akinari, Sumida, Keiichi, Yamanouchi, Masayuki, Hayami, Noriko, Suwabe, Tatsuya, Hiramatsu, Rikako, Hasegawa, Eiko, Sawa, Naoki, Fujii, Takeshi, Hara, Shigeko, Sugiyama, Hitoshi, Makino, Hirofumi, Wada, Jun, Ohashi, Kenichi, Takaichi, Kenmei, Ubara, Yoshifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557586/
https://www.ncbi.nlm.nih.gov/pubmed/28813476
http://dx.doi.org/10.1371/journal.pone.0183190
_version_ 1783257237209219072
author Mise, Koki
Yamaguchi, Yutaka
Hoshino, Junichi
Ueno, Toshiharu
Sekine, Akinari
Sumida, Keiichi
Yamanouchi, Masayuki
Hayami, Noriko
Suwabe, Tatsuya
Hiramatsu, Rikako
Hasegawa, Eiko
Sawa, Naoki
Fujii, Takeshi
Hara, Shigeko
Sugiyama, Hitoshi
Makino, Hirofumi
Wada, Jun
Ohashi, Kenichi
Takaichi, Kenmei
Ubara, Yoshifumi
author_facet Mise, Koki
Yamaguchi, Yutaka
Hoshino, Junichi
Ueno, Toshiharu
Sekine, Akinari
Sumida, Keiichi
Yamanouchi, Masayuki
Hayami, Noriko
Suwabe, Tatsuya
Hiramatsu, Rikako
Hasegawa, Eiko
Sawa, Naoki
Fujii, Takeshi
Hara, Shigeko
Sugiyama, Hitoshi
Makino, Hirofumi
Wada, Jun
Ohashi, Kenichi
Takaichi, Kenmei
Ubara, Yoshifumi
author_sort Mise, Koki
collection PubMed
description AIMS: Glomerular insudative lesions are a pathological hallmark of diabetic nephropathy (DN). However, paratubular basement membrane insudative lesions (PTBMIL) have not attracted much attention, and the association between such lesions and the renal prognosis remains unclear. METHODS: Among 142 patients with biopsy-proven DN and type 2 diabetes encountered from 1998 to 2011, 136 patients were enrolled in this study. Patients were classified into 3 groups (Group 1: mild, Group 2: moderate, Group 3: severe) according to the extent of cortical and medullary PTBMIL. The endpoint was a decline of the estimated glomerular filtration rate (eGFR) by ≥ 40% from baseline or commencement of dialysis for end-stage renal disease. The Cox proportional hazard model was employed to calculate hazard ratios (HRs) and 95% confidence interval (CIs) for the death-censored endpoint. RESULTS: During a median follow-up period of 1.8 years (IQR: 0.9–3.5), the endpoint occurred in 104 patients. Baseline mean eGFR was 43.9 ± 22.8 ml/min/1.73 m(2), and 125 patients (92%) had overt proteinuria. After adjusting for known indicators of DN progression, the HR for the endpoint was 2.32 (95% CI: 1.20–4.51) in PTBMIL Group 2 and 3.12 (1.48–6.58) in PTBMIL Group 3 versus PTBMIL Group 1. Furthermore, adding the PTBMIL Group to a multivariate model including known promoters of DN progression improved prediction of the endpoint (c-index increased by 0.02 [95% CI: 0.00–0.04]). CONCLUSIONS: PTBMIL may be useful for predicting the renal prognosis of patients with biopsy-proven DN, but further investigation of these lesions in various stages of DN is needed.
format Online
Article
Text
id pubmed-5557586
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-55575862017-08-25 Paratubular basement membrane insudative lesions predict renal prognosis in patients with type 2 diabetes and biopsy-proven diabetic nephropathy Mise, Koki Yamaguchi, Yutaka Hoshino, Junichi Ueno, Toshiharu Sekine, Akinari Sumida, Keiichi Yamanouchi, Masayuki Hayami, Noriko Suwabe, Tatsuya Hiramatsu, Rikako Hasegawa, Eiko Sawa, Naoki Fujii, Takeshi Hara, Shigeko Sugiyama, Hitoshi Makino, Hirofumi Wada, Jun Ohashi, Kenichi Takaichi, Kenmei Ubara, Yoshifumi PLoS One Research Article AIMS: Glomerular insudative lesions are a pathological hallmark of diabetic nephropathy (DN). However, paratubular basement membrane insudative lesions (PTBMIL) have not attracted much attention, and the association between such lesions and the renal prognosis remains unclear. METHODS: Among 142 patients with biopsy-proven DN and type 2 diabetes encountered from 1998 to 2011, 136 patients were enrolled in this study. Patients were classified into 3 groups (Group 1: mild, Group 2: moderate, Group 3: severe) according to the extent of cortical and medullary PTBMIL. The endpoint was a decline of the estimated glomerular filtration rate (eGFR) by ≥ 40% from baseline or commencement of dialysis for end-stage renal disease. The Cox proportional hazard model was employed to calculate hazard ratios (HRs) and 95% confidence interval (CIs) for the death-censored endpoint. RESULTS: During a median follow-up period of 1.8 years (IQR: 0.9–3.5), the endpoint occurred in 104 patients. Baseline mean eGFR was 43.9 ± 22.8 ml/min/1.73 m(2), and 125 patients (92%) had overt proteinuria. After adjusting for known indicators of DN progression, the HR for the endpoint was 2.32 (95% CI: 1.20–4.51) in PTBMIL Group 2 and 3.12 (1.48–6.58) in PTBMIL Group 3 versus PTBMIL Group 1. Furthermore, adding the PTBMIL Group to a multivariate model including known promoters of DN progression improved prediction of the endpoint (c-index increased by 0.02 [95% CI: 0.00–0.04]). CONCLUSIONS: PTBMIL may be useful for predicting the renal prognosis of patients with biopsy-proven DN, but further investigation of these lesions in various stages of DN is needed. Public Library of Science 2017-08-15 /pmc/articles/PMC5557586/ /pubmed/28813476 http://dx.doi.org/10.1371/journal.pone.0183190 Text en © 2017 Mise et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Mise, Koki
Yamaguchi, Yutaka
Hoshino, Junichi
Ueno, Toshiharu
Sekine, Akinari
Sumida, Keiichi
Yamanouchi, Masayuki
Hayami, Noriko
Suwabe, Tatsuya
Hiramatsu, Rikako
Hasegawa, Eiko
Sawa, Naoki
Fujii, Takeshi
Hara, Shigeko
Sugiyama, Hitoshi
Makino, Hirofumi
Wada, Jun
Ohashi, Kenichi
Takaichi, Kenmei
Ubara, Yoshifumi
Paratubular basement membrane insudative lesions predict renal prognosis in patients with type 2 diabetes and biopsy-proven diabetic nephropathy
title Paratubular basement membrane insudative lesions predict renal prognosis in patients with type 2 diabetes and biopsy-proven diabetic nephropathy
title_full Paratubular basement membrane insudative lesions predict renal prognosis in patients with type 2 diabetes and biopsy-proven diabetic nephropathy
title_fullStr Paratubular basement membrane insudative lesions predict renal prognosis in patients with type 2 diabetes and biopsy-proven diabetic nephropathy
title_full_unstemmed Paratubular basement membrane insudative lesions predict renal prognosis in patients with type 2 diabetes and biopsy-proven diabetic nephropathy
title_short Paratubular basement membrane insudative lesions predict renal prognosis in patients with type 2 diabetes and biopsy-proven diabetic nephropathy
title_sort paratubular basement membrane insudative lesions predict renal prognosis in patients with type 2 diabetes and biopsy-proven diabetic nephropathy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557586/
https://www.ncbi.nlm.nih.gov/pubmed/28813476
http://dx.doi.org/10.1371/journal.pone.0183190
work_keys_str_mv AT misekoki paratubularbasementmembraneinsudativelesionspredictrenalprognosisinpatientswithtype2diabetesandbiopsyprovendiabeticnephropathy
AT yamaguchiyutaka paratubularbasementmembraneinsudativelesionspredictrenalprognosisinpatientswithtype2diabetesandbiopsyprovendiabeticnephropathy
AT hoshinojunichi paratubularbasementmembraneinsudativelesionspredictrenalprognosisinpatientswithtype2diabetesandbiopsyprovendiabeticnephropathy
AT uenotoshiharu paratubularbasementmembraneinsudativelesionspredictrenalprognosisinpatientswithtype2diabetesandbiopsyprovendiabeticnephropathy
AT sekineakinari paratubularbasementmembraneinsudativelesionspredictrenalprognosisinpatientswithtype2diabetesandbiopsyprovendiabeticnephropathy
AT sumidakeiichi paratubularbasementmembraneinsudativelesionspredictrenalprognosisinpatientswithtype2diabetesandbiopsyprovendiabeticnephropathy
AT yamanouchimasayuki paratubularbasementmembraneinsudativelesionspredictrenalprognosisinpatientswithtype2diabetesandbiopsyprovendiabeticnephropathy
AT hayaminoriko paratubularbasementmembraneinsudativelesionspredictrenalprognosisinpatientswithtype2diabetesandbiopsyprovendiabeticnephropathy
AT suwabetatsuya paratubularbasementmembraneinsudativelesionspredictrenalprognosisinpatientswithtype2diabetesandbiopsyprovendiabeticnephropathy
AT hiramatsurikako paratubularbasementmembraneinsudativelesionspredictrenalprognosisinpatientswithtype2diabetesandbiopsyprovendiabeticnephropathy
AT hasegawaeiko paratubularbasementmembraneinsudativelesionspredictrenalprognosisinpatientswithtype2diabetesandbiopsyprovendiabeticnephropathy
AT sawanaoki paratubularbasementmembraneinsudativelesionspredictrenalprognosisinpatientswithtype2diabetesandbiopsyprovendiabeticnephropathy
AT fujiitakeshi paratubularbasementmembraneinsudativelesionspredictrenalprognosisinpatientswithtype2diabetesandbiopsyprovendiabeticnephropathy
AT harashigeko paratubularbasementmembraneinsudativelesionspredictrenalprognosisinpatientswithtype2diabetesandbiopsyprovendiabeticnephropathy
AT sugiyamahitoshi paratubularbasementmembraneinsudativelesionspredictrenalprognosisinpatientswithtype2diabetesandbiopsyprovendiabeticnephropathy
AT makinohirofumi paratubularbasementmembraneinsudativelesionspredictrenalprognosisinpatientswithtype2diabetesandbiopsyprovendiabeticnephropathy
AT wadajun paratubularbasementmembraneinsudativelesionspredictrenalprognosisinpatientswithtype2diabetesandbiopsyprovendiabeticnephropathy
AT ohashikenichi paratubularbasementmembraneinsudativelesionspredictrenalprognosisinpatientswithtype2diabetesandbiopsyprovendiabeticnephropathy
AT takaichikenmei paratubularbasementmembraneinsudativelesionspredictrenalprognosisinpatientswithtype2diabetesandbiopsyprovendiabeticnephropathy
AT ubarayoshifumi paratubularbasementmembraneinsudativelesionspredictrenalprognosisinpatientswithtype2diabetesandbiopsyprovendiabeticnephropathy